Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $97

Author: Benzinga Newsdesk | March 20, 2024 07:12am
B of A Securities analyst Allen Lutz maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $93 to $97.

Posted In: HQY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist